{"count": 4, "results": [{"_id": "35240246", "pmid": 35240246, "title": "Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet.", "journal": "Brain Res Bull", "authors": ["Deng W", "Li F", "Ke H", "Wang S", "Li Z", "Lv P", "Chen Y"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.brainresbull.2022.02.021", "meta_date_publication": "2022 Jun 1", "meta_volume": "183", "meta_issue": "", "meta_pages": "172-183", "score": 50243.984, "text_hl": "HFD consumption markedly aggravated @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@repetitive behaviors@@@ in the self-grooming test. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ reduced HFD-induced @<m>DISEASE_Hyperkinesis</m> @DISEASE_MESH:D006948 @@@hyperactivity@@@. ", "citations": {"NLM": "Deng W, Li F, Ke H, Wang S, Li Z, Lv P, Chen Y. Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet. Brain Res Bull. 2022 Jun 1;183():172-183. PMID: 35240246", "BibTeX": "@article{35240246, title={Effect of metformin in autistic BTBR T + Itpr3tf/J mice administered a high-fat diet.}, author={Deng W and Li F and Ke H and Wang S and Li Z and Lv P and Chen Y}, journal={Brain Res Bull}, volume={183}, pages={172-183}}"}}, {"_id": "39181309", "pmid": 39181309, "title": "Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.", "journal": "Prog Neuropsychopharmacol Biol Psychiatry", "authors": ["Zhao Y", "Fei L", "Duan Y"], "date": "2024-08-22T00:00:00Z", "doi": "10.1016/j.pnpbp.2024.111128", "meta_date_publication": "2024 Aug 22", "meta_volume": "135", "meta_issue": "", "meta_pages": "111128", "score": 50231.918, "text_hl": "RESULTS: Among 11,729 cases of motor adverse events in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ @SPECIES_9606 @@@patients@@@, six categories of @DISEASE_Diabetes_Complications @DISEASE_MESH:D048909 @@@drMD@@@ were significantly associated with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ medications. Noticeably, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was revealed to drastically increase the incidence of @DISEASE_Parkinson_Disease_Secondary @DISEASE_MESH:D010302 @@@parkinsonism@@@ (adjusted ROR:3.97; 95 %CI (3.03, 5.19), p = 5.68e-24), @DISEASE_Hypokinesia @DISEASE_MESH:D018476 @@@bradykinesia@@@ (adjusted ROR:1.69; 95 %CI (1.07,2.59), p = 0.02) and irregular @<m>DISEASE_Hyperkinesis</m> @DISEASE_MESH:D006948 @@@hyperkinesia@@@, including @DISEASE_Chorea @DISEASE_MESH:D002819 @@@chorea@@@, @DISEASE_Choreoathetosis_Hypothyroidism_And_Neonatal_Respiratory_Distress @DISEASE_MESH:C567034 @@@choreoathetosis@@@ and @DISEASE_Athetosis @DISEASE_MESH:D001264 @@@athetosis@@@. ", "citations": {"NLM": "Zhao Y, Fei L, Duan Y. Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 22;135():111128. PMID: 39181309", "BibTeX": "@article{39181309, title={Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.}, author={Zhao Y and Fei L and Duan Y}, journal={Prog Neuropsychopharmacol Biol Psychiatry}, volume={135}, pages={111128}}"}}, {"_id": "31520524", "pmid": 31520524, "pmcid": "PMC6825840", "title": "Metformin treatment in young children with fragile X syndrome", "journal": "Mol Genet Genomic Med", "authors": ["Biag HMB", "Potter LA", "Wilkins V", "Afzal S", "Rosvall A", "Salcedo-Arellano MJ", "Rajaratnam A", "Manzano-Nunez R", "Schneider A", "Tassone F", "Rivera SM", "Hagerman RJ"], "date": "2019-11-01T00:00:00Z", "doi": "10.1002/mgg3.956", "meta_date_publication": "2019 Nov", "meta_volume": "7", "meta_issue": "11", "meta_pages": "e956", "score": 50054.29, "text_hl": "Previously, a case series of children and adults with @DISEASE_Fragile_X_Syndrome @DISEASE_MESH:D005600 @@@FXS@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ demonstrated improvements in @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@irritability@@@, social responsiveness, language, and @<m>DISEASE_Hyperkinesis</m> @DISEASE_MESH:D006948 @@@hyperactivity@@@.", "citations": {"NLM": "Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, Schneider A, Tassone F, Rivera SM, Hagerman RJ. Metformin treatment in young children with fragile X syndrome Mol Genet Genomic Med. 2019 Nov;7(11):e956. PMID: 31520524", "BibTeX": "@article{31520524, title={Metformin treatment in young children with fragile X syndrome}, author={Biag HMB and Potter LA and Wilkins V and Afzal S and Rosvall A and Salcedo-Arellano MJ and Rajaratnam A and Manzano-Nunez R and Schneider A and Tassone F and Rivera SM and Hagerman RJ}, journal={Mol Genet Genomic Med}, volume={7}, number={11}, pages={e956}}"}}, {"_id": "28436599", "pmid": 28436599, "title": "Metformin as targeted treatment in fragile X syndrome.", "journal": "Clin Genet", "authors": ["Dy ABC", "Tassone F", "Eldeeb M", "Salcedo-Arellano MJ", "Tartaglia N", "Hagerman R"], "date": "2018-02-01T00:00:00Z", "doi": "10.1111/cge.13039", "meta_date_publication": "2018 Feb", "meta_volume": "93", "meta_issue": "2", "meta_pages": "216-222", "score": 50053.746, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as targeted treatment in @DISEASE_Fragile_X_Syndrome @DISEASE_MESH:D005600 @@@fragile X syndrome@@@.", "citations": {"NLM": "Dy ABC, Tassone F, Eldeeb M, Salcedo-Arellano MJ, Tartaglia N, Hagerman R. Metformin as targeted treatment in fragile X syndrome. Clin Genet. 2018 Feb;93(2):216-222. PMID: 28436599", "BibTeX": "@article{28436599, title={Metformin as targeted treatment in fragile X syndrome.}, author={Dy ABC and Tassone F and Eldeeb M and Salcedo-Arellano MJ and Tartaglia N and Hagerman R}, journal={Clin Genet}, volume={93}, number={2}, pages={216-222}}"}}]}